Restoring Confidence in the World Anti-Doping Agency Act of 2025 · Introduced in House (2025-01-23)

119th CONGRESS 1st Session

To amend the Office of National Drug Control Policy Reauthorization Act of 2006 to modify the authority of the Office of National Drug Control Policy with respect to the World Anti-Doping Agency, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES · January 23, 2025 · Sponsor: Mr. Moolenaar · Committee: Committee on Energy and Commerce

SEC. 2. Authority of National Drug Control Policy with respect to the World Anti-Doping Agency

Section 701 of the Office of National Drug Control Policy Reauthorization Act of 2006 () is amended— 21 U.S.C. 2001

in subsection (a)—
- (1) United States Olympic and Paralympic Committee
  - The term United States Olympic and Paralympic Committee means the organization established by of title 36, United States Code. chapter 2205
- by amending paragraph (1) to read as follows:
- in paragraph (3), by striking and inserting ;
- by redesignating paragraphs (1) and (3) as paragraphs (4) and (1), respectively, and moving the paragraphs so as to appear in numeric order; and
  - (3) Independent athlete
    - The term independent athlete means an Olympic or Paralympic athlete who does not serve, in any capacity—
      - on the International Olympic Committee;
      - on the International Paralympic Committee;
      - at an international sports federation recognized by the International Olympic Committee or the International Paralympic Committee;
      - on the United States Olympic and Paralympic Committee; or
      - at the World Anti-Doping Agency.
- by inserting after paragraph (2) the following:
in subsection (b)—
- by striking each place it appears and inserting United States Olympic and Paralympic Committee;
- in paragraph (5), by striking the period at the end and inserting ; and; and
  - carry out responsibilities with respect to the World Anti-Doping Agency, as described in subsection (d).
- by adding at the end the following:
- (d) Authority with respect to the World Anti-Doping Agency
  - (1) In general
    - The Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Team USA Athletes’ Commission, shall—
      - use all available tools to ensure that—
        
        (i) the World Anti-Doping Agency has a credible and independent governance model that provides for fair representation of the United States;
        
        (ii) the World Anti-Doping Agency fully implements all governance reforms, including a proper conflict-of-interest policy for all members of the Executive Committee, the Foundation Board, and all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency; and
        
        (iii) independent athletes from the United States and other democratic countries, or representatives of such athletes, have decision-making roles on the Executive Committee and the Foundation Board, and in all relevant expert advisory groups, standing committees, permanent special committees, and working groups, of the World Anti-Doping Agency;
      - demonstrate leadership within the global community;
      - have strict standards that work toward countering doping in every form, including by countering systemic fraud through doping involving—
        
        (i) governmental law enforcement, intelligence, or anti-doping institutions;
        
        (ii) sporting organizations; or
        
        (iii) athlete support personnel; and
      - work collaboratively with democratic countries.
  - (2) Determination
    - (A) In general
      - Not later than 90 days after the date of the enactment of this subsection, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Team USA Athletes’ Commission, shall make a determination as to whether the World Anti-Doping Agency—
        
        (i) has a credible and independent governance model that provides for fair representation of the United States;
        
        (ii) fully implements all governance reforms, including a proper conflict-of-interest policy described in paragraph (1)(A)(ii); and
        
        (iii) allows independent athletes from the United States and other democratic countries, or representatives of such athletes, to have decision-making roles on the Executive Committee and the Foundation Board, and in all relevant expert advisory groups, standing committees, permanent special committees, and working groups, of the World Anti-Doping Agency.
by adding at the end the following:

H.R. 693

Table of contents

SEC. 1. Short title

SEC. 2. Authority of National Drug Control Policy with respect to the World Anti-Doping Agency